Skinvisible's value lies in its ability to continually generate new IP on dermatology and medical products formulated with Invisicare®. Patent approvals are sought (initially in the U.S. and later internationally) for all products developed. There are 4 patents approved, 9 U.S. patents pending in addition to 34 PCTs internationally, with many more to be filed. Some of these PCT patents cover up to five products. All patents with Invisicare® are owned by Skinvisible.
Patent Components (Combined or Individually):
Granted Patents & Trademarks
United States Patents Granted
United States Patent No.: 6,756,059
Granted: June 29, 2004
Topical composition, topical composition precursor, and methods for manufacturing and using.
United States Patent No.: 6,582,683
Granted: June 24, 2003
Dermal barrier composition.
International Patents Granted
India Patent
Granted: July 26, 2007
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.
Australia Patent
Granted: June 3, 2008
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.
Japan Patent
Granted: October 31, 2008
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.
China Patent
Granted: July 1, 2009
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.
Korea Patent
Granted: February 9, 2010
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.
Hong Kong Patent
Granted: July 27, 2010
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.
|
Latest Press Releases:
July 27, 2010
Skinvisible's Invisicare Patent Portfolio Strengthens
- Hong Kong Patent Granted for Polymer Technology
July 20, 2010
Skinvisible Signs DermSafe Agreement for Europe and China
- RHEI Pharmaceuticals Adds Alcohol-Free Hand Sanitizer to Its Product Line
July 13, 2010
Skinvisible Licenses Invisicare Products for US, China and Europe
- Rhei Pharmaceuticals Receives Exclusivity for Three Skincare Formulations
April 13, 2010
Skinvisible Signs Development Agreement for Prescription Product for Women's Healthcare
- Women's Choice Pharmaceuticals chooses Invisicare for new products
CLICK HERE TO READ ALL NEWS RELEASES
Research & Development
Technology Overview
|